- Funding Needed
- $173 (Mio)
- EB5 Funding
- $10 (Mio)
- Amount Subscribed
- $173 (Mio)
- EB-5 Investors
- Investment Amount
- Subscription Fee
- Job Creation per Investor
- Job Creation (Total)
- Healthcare and Social Assistance
- General Medical and Surgical Hospitals
- Amount of EB-5 investors anticipated for this phase?
- Expected Maturity
- 5 years
- Expected Return
- 1% to investor
- Principal equity in project?
- Does this project have approved I-526's?
- Does this Regional Center have approved I-526's?
- Does this Regional Center have approved I-829's?
- New York
- 875 Ellicott Street, Buffalo, NY
- Last Update: July 31, 2016 12:39 PM
Your Project was viewed 39 times (totally).
For the last 7 days 0 times.
Gates Vascular Institute
- Developer Name
- Kaleida Health
The Gates Vascular Institute (“GVI”) is a $173 million, state-of-the-art medical facility on the Buffalo Niagara Medical Campus near downtown Buffalo, New York. The GVI boasts a combination of the finest researchers, surgeons, physicians, and other clinicians devoted to the study, treatment and prevention of cardiac, stroke and vascular diseases and celebrated its grand opening in May of 2012. To date, all I-526 petitions and I-829 petitions have been approved and EB-5 investors are being repaid their $500,000 investment.
This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.